Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jeng-Shiuan Tsai"'
Autor:
Yi Ting Yen, Wu Chou Su, Chao Chun Chang, Po Lan Su, Chien Chung Lin, Wu Wei Lai, Chia Ying Lin, Jeng Shiuan Tsai, Szu Chun Yang, Yau Lin Tseng
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 9, Pp 1729-1739 (2021)
Background Recent study showed that the combination of erlotinib and bevacizumab had better disease control than erlotinib monotherapy in patients with advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Howeve
Autor:
Yau Lin Tseng, Wu Chou Su, Chia Ying Lin, Meng-Chih Lin, Chao Chun Chang, Yi Lin Wu, Szu Chun Yang, Yi Ting Yen, Po Lan Su, Chien Chung Lin, Jeng Shiuan Tsai, Chin Chou Wang
Publikováno v:
Lung Cancer. 158:137-145
OBJECTIVES Osimertinib is the main treatment choice for pretreated patients with advanced non-small cell lung cancer (NSCLC) harbouring epidermal growth factor receptor (EGFR) T790M mutations. However, the choice of subsequent therapy when progressiv